Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results

BACKGROUND: To report toxicity and early clinical outcomes of hypofractionated simultaneous integrated boost (SIB) approach with Volumetric Modulated Arc Therapy (VMAT) as adjuvant treatment after breast-conserving surgery. METHODS: Patients presenting early-stage breast cancer were enrolled in a ph...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Radiat Oncol
Autori principali: De Rose, Fiorenza, Fogliata, Antonella, Franceschini, Davide, Navarria, Piera, Villa, Elisa, Iftode, Cristina, D’Agostino, Giuseppe, Cozzi, Luca, Lobefalo, Francesca, Mancosu, Pietro, Tomatis, Stefano, Scorsetti, Marta
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2016
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5027088/
https://ncbi.nlm.nih.gov/pubmed/27639373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-016-0701-z
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi